Literature DB >> 30399599

Aminophenols increase proliferation of thyroid tumor cells by inducing the transcription factor activity of estrogen receptor α.

Lin Wang1, Ling Zhao2, Xiaomeng Jia3, Lina Jiang4, Yeqiong Song5, Qinong Ye6, Zhaohui Lyu7.   

Abstract

Aminophenols, which are widely used as components of hair dye and medicine, may function as environmental endocrine disruptors by regulating the proliferation of endocrine-related cancers. Estrogen receptor α (ERα) is a key regulator of breast cancer. Recently, it was found that ERα may also participate in the transformation and progression of thyroid tumors, but its interaction with aminophenols and its function in thyroid tumors is not clear. In this study, the transcription factor activity of ERα in BHP10-3 cells (a thyroid tumor cell line) was examined using luciferase assays. The promoter recruitment of ERα was examined using chromatin co-precipitation (ChIP). Additionally, in an in vivo study, BHP10-3 cells were transplanted into nude mice. Upon administration of aminophenols, the transcription factor activity of ERα was significantly increased in BHP10-3 cells, and the recruitment of ERα to the promoter of its target gene was increased. Aminophenols enhanced the in vitro and in vivo proliferation of BHP10-3 cells. By discovering that aminophenols induce the onco-promoting activity of ERα, our study extends the understanding of the function of aminophenols and suggests that ERα is a potential therapeutic target for the treatment of thyroid tumors.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aminophenols; Estrogen receptor α; Thyroid tumor; Transcription factor activation

Mesh:

Substances:

Year:  2018        PMID: 30399599     DOI: 10.1016/j.biopha.2018.10.168

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway.

Authors:  Qing-Ping Shao; Chen Wei; Jie Yang; Wen-Zhou Zhang
Journal:  Onco Targets Ther       Date:  2020-07-27       Impact factor: 4.147

2.  A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.

Authors:  Shu Wang; Yingshi Zhang; Tianshu Ren; Qiong Wu; Hongyuan Lu; Xiaochun Qin; Yuyan Liu; Huaiwei Ding; Qingchun Zhao
Journal:  Cell Death Dis       Date:  2020-06-30       Impact factor: 8.469

3.  ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance.

Authors:  Xudong Gao; Hebing Chen; Xin Huang; Hao Li; Zhen Liu; Xiaochen Bo
Journal:  Onco Targets Ther       Date:  2019-02-26       Impact factor: 4.147

4.  A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells.

Authors:  Yan Huo; Qun Wang; Ying Liu; Junyi Wang; Qian Li; Zongyuan Li; Yan Dong; Yifei Huang; Liqiang Wang
Journal:  Onco Targets Ther       Date:  2019-07-30       Impact factor: 4.147

5.  The multiple-kinase inhibitor lenvatinib inhibits the proliferation of acute myeloid leukemia cells.

Authors:  Fan Feng; Xiaojuan Li; Ruisheng Li; Boan Li
Journal:  Animal Model Exp Med       Date:  2019-09-03

6.  miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib.

Authors:  Leisheng Wang; He En; Lei Yang; Yanbing Zhang; Baisheng Sun; Jianjiang Gao
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

7.  SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity.

Authors:  Fan Yin; Fan Feng; Lei Wang; Xiaoning Wang; Zongwei Li; Yu Cao
Journal:  Cell Death Dis       Date:  2019-09-11       Impact factor: 8.469

8.  TPX2 Enhanced the Activation of the HGF/ETS-1 Pathway and Increased the Invasion of Endocrine-Independent Prostate Carcinoma Cells.

Authors:  Qinghong Zhou; Mingsheng Liu; Tao Shao; Pingbo Xie; Shaojie Zhu; Wei Wang; Qiong Miao; Jiaxi Peng; Peng Zhang
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 5.738

9.  FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis.

Authors:  Hua Yang; Lili Ren; Yanan Wang; Xuebing Bi; Xiaoli Li; Ming Wen; Qian Zhang; Yang Yang; Youchao Jia; Yumiao Li; Aimin Zang; Yaning Wei; Guanghai Dai
Journal:  Cell Death Dis       Date:  2020-10-13       Impact factor: 8.469

10.  MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Receptor.

Authors:  Qiyu Jiang; Yan Ma; Jingjing Han; Jingdong Chu; Xuemei Ma; Lijun Shen; Bo Liu; Bo-An Li; Jun Hou; Qian Bi
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.